Neurothera Labs Inc. (TSXV:NTLX)
Canada · Delayed Price · Currency is CAD 0.1800
0.00 (0.00%)
At close: Jun 3, 2026
Neurothera Labs Company Description
Neurothera Labs Inc. engages in the development of a portfolio of drugs based on cannabinoid molecules.
The company develops programs based on tetrahydrocannabinol (THC) and/or non-psychoactive cannabidiol for the treatment of Tourette syndrome, Alzheimer’s disease and agitation, autism spectrum disorder, and status epilepticus.
It also focuses on e-commerce operations, which sells hemp-based products. Neurothera Labs Inc. was formerly known as Miza III Ventures Inc. The company is based in Newark, Delaware.
Neurothera Labs Inc. is a subsidiary of SciSparc Ltd.
Neurothera Labs Inc.
| Country | Canada |
| Industry | Drug Manufacturers - General |
| Sector | Healthcare |
| CEO | Oz Adler |
Contact Details
Address: 18 Shea Way Newark, Delaware 19713 United States | |
| Website | neurothera.com |
Stock Details
| Ticker Symbol | NTLX |
| Exchange | TSX Venture Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Oz Adler CPA | Chief Executive Officer |
| Gabriel Kabazo | Chief Financial Officer and Corporate Secretary |
| Michal Efraty | IR Manager |